Bristol Myers Squibb (CELG-RI) Dividends payables (2009 - 2015)

Bristol Myers Squibb (CELG-RI) posted quarterly Dividends payables of $655.0 million for Q4 2015, up 1.55% YoY from $645.0 million in Q4 2014, and up 2.99% sequentially from $636.0 million in Q3 2015.

Bristol Myers Squibb (CELG-RI) Dividends payables (2009 - 2015) Analysis & Trends

Bristol Myers Squibb has disclosed Dividends payables across 7 years of filings, most recently posting $655.0 million for Q4 2015.

  • In Q4 2015, Dividends payables rose 1.55% year-over-year to $655.0 million; the TTM figure through Dec 2015 stood at $655.0 million (up 1.55% YoY), while the FY2015 annual figure was $655.0 million, up 1.55% from the prior year.
  • Dividends payables climbed to $655.0 million in Q4 2015, from $636.0 million in the prior quarter.
  • Over the last five years, Dividends payables for CELG-RI reached as high as $655.0 million in Q4 2015 and fell as low as $578.0 million in Q1 2011.
  • The 5-year median for Dividends payables is $608.5 million (2012), against an average of $612.2 million.
  • The widest YoY moves for Dividends payables: up 4.62% in 2013, down 1.34% in 2013.
  • A 5-year view of Dividends payables shows it stood at $597.0 million in 2011, then gained by 1.51% to $606.0 million in 2012, then increased by 4.62% to $634.0 million in 2013, then climbed by 1.74% to $645.0 million in 2014, then increased by 1.55% to $655.0 million in 2015.
  • According to Business Quant data, Dividends payables over the past three periods registered $655.0 million, $636.0 million, and $634.0 million for Q4 2015, Q3 2015, and Q2 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.14 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Bristol Myers Squibb 244.56 Mn -10.21 Bn 8.07 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 655.00 Mn
Sep 30, 2015 636.00 Mn
Jun 30, 2015 634.00 Mn
Mar 31, 2015 633.00 Mn
Dec 31, 2014 645.00 Mn
Sep 30, 2014 623.00 Mn
Jun 30, 2014 621.00 Mn
Mar 31, 2014 619.00 Mn
Dec 31, 2013 634.00 Mn
Sep 30, 2013 611.00 Mn
Jun 30, 2013 606.00 Mn
Mar 31, 2013 601.00 Mn
Dec 31, 2012 606.00 Mn
Sep 30, 2012 596.00 Mn
Jun 30, 2012 598.00 Mn
Mar 31, 2012 593.00 Mn
Dec 31, 2011 597.00 Mn
Sep 30, 2011 578.00 Mn
Jun 30, 2011 579.00 Mn
Mar 31, 2011 578.00 Mn